Trametinib-based Treatment of Pediatric CNS Tumors: A Single Institutional Experience
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Pediatric Hematology/Oncology"
DOI: 10.1097/mph.0000000000001819
Abstract: MEK inhibitors are an emerging therapy with increasing use in mitogen-activated protein kinase-driven central nervous system (CNS) tumors. There is limited data regarding efficacy and toxicity in pediatric patients. We report our clinical experience with… read more here.
Keywords: therapy; cns tumors; treatment; trametinib based ... See more keywords